[ad_1]
As per the ranking rationle report, the scores proceed to replicate the in depth expertise of promoters within the pharmaceutical business, and wholesome monetary danger profile. These strengths are partially offset by the working capital-intensive operations, and susceptibility of working profitability to volatility in uncooked materials costs.
Additional, for arriving at its scores, CRISIL Scores continues to totally consolidate the enterprise and monetary danger profiles of Kopran Restricted (Kopran) and its wholly-owned subsidiaries, collectively known as the Kopran group, as they’re in the same line of enterprise and have important operational and monetary linkages.
At round 12:03 PM, Kopran was buying and selling at Rs228.85 apiece up by Rs2.05 or 0.9% on the BSE.
[ad_2]
Source link